Item 7.01 Regulation FD Disclosure.

As previously announced, on January 11, 2021, Teladoc Health, Inc. (the "Company") will present at the 39th Annual J.P. Morgan Healthcare Conference (the "Conference"), beginning at 10:00 a.m. Eastern Time. A copy of the materials to be presented by the Company at the Conference is furnished herewith as Exhibit 99.1. There will be a live audio webcast of the event accessible via the Company's Investor Relations website at http://ir.teladoc.com.

The information in this Item 7.01 and Exhibit 99.1 is furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and such information shall not be deemed to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.





(d)  Exhibits.



Exhibit No.                                Description
  99.1             Teladoc Health, Inc. slide presentation, dated January 11,
                 2021.
104              The cover page of this Current Report on Form 8-K formatted as
                 Inline XBRL.

© Edgar Online, source Glimpses